Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288445672> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W4288445672 endingPage "542" @default.
- W4288445672 startingPage "537" @default.
- W4288445672 abstract "Vitiligo is a disease that negatively influences patients quality of life, lowers their self-esteem, and causes significant psychological discomfort. According to numerous studies, patients with vitiligo are more likely to develop depressive and anxiety disorders, suicidal thoughts. Despite the prevalence and social significance of the disease, vitiligo therapy remains a topical issue today. So, at the moment in the world there are still no specially registered drugs and treatments for vitiligo. Therapy of the disease today is mainly represented by drugs from the group of corticosteroids and calcineurin inhibitors, both in the form of monotherapy and in the form of combination therapy with narrow band UVB phototherapy. However, the overall effectiveness of standard treatment regimens does not exceed 80%, and the relapse rate can be up to 75%, which does not meet the expectations of the patient and the dermatovenerologist.
 This article is of a review character. The aim of the article was to study new promising methods of treatment of the disease in the practice of Russian and foreign specialists, their availability and principles of action.
 A systematic literature review was performed using PubMed, Cochrane Library, Clinicaltrials.gov, Cyberleninka, and Internet databases to identify new drugs/methods in development, in clinical trials, and soon to be on the biopharmaceutical market. Keywords such as vitiligo, quality of life, and treatment were used in the literature search of the above-mentioned databases. The results of various clinical trials are given. The review identified the main contenders for the role of long-term therapy for vitiligo, which in the future will optimize patient management tactics and adherence to treatment.
 This review, addressed to practicing dermatovenerologists interested in vitiligo therapy, points to a process of active research and development of new therapies, in which more than 20 biopharmaceutical companies worldwide are currently involved. It should be expected that in the next few years the range of drugs used to treat the disease will completely change. Based on recent research on the pathogenesis of vitiligo, it can be concluded that from the entire list of promising drugs, local janus kinase inhibitors are probably the most promising new class of drugs for the treatment of this disease." @default.
- W4288445672 created "2022-07-29" @default.
- W4288445672 creator A5081730088 @default.
- W4288445672 date "2022-07-28" @default.
- W4288445672 modified "2023-09-30" @default.
- W4288445672 title "Vitiligo treatment: a look into the future (literature review)" @default.
- W4288445672 cites W2580870032 @default.
- W4288445672 cites W2944529732 @default.
- W4288445672 cites W3001922907 @default.
- W4288445672 cites W3094298448 @default.
- W4288445672 cites W3117407160 @default.
- W4288445672 cites W3159116143 @default.
- W4288445672 cites W3164472312 @default.
- W4288445672 cites W3179713661 @default.
- W4288445672 cites W3197016111 @default.
- W4288445672 cites W3216044401 @default.
- W4288445672 doi "https://doi.org/10.17816/dv101158" @default.
- W4288445672 hasPublicationYear "2022" @default.
- W4288445672 type Work @default.
- W4288445672 citedByCount "1" @default.
- W4288445672 countsByYear W42884456722023 @default.
- W4288445672 crossrefType "journal-article" @default.
- W4288445672 hasAuthorship W4288445672A5081730088 @default.
- W4288445672 hasBestOaLocation W42884456721 @default.
- W4288445672 hasConcept C118552586 @default.
- W4288445672 hasConcept C126322002 @default.
- W4288445672 hasConcept C142724271 @default.
- W4288445672 hasConcept C15744967 @default.
- W4288445672 hasConcept C159110408 @default.
- W4288445672 hasConcept C16005928 @default.
- W4288445672 hasConcept C17744445 @default.
- W4288445672 hasConcept C177713679 @default.
- W4288445672 hasConcept C189708586 @default.
- W4288445672 hasConcept C199539241 @default.
- W4288445672 hasConcept C204787440 @default.
- W4288445672 hasConcept C2779134260 @default.
- W4288445672 hasConcept C2779473830 @default.
- W4288445672 hasConcept C2779951463 @default.
- W4288445672 hasConcept C2779980618 @default.
- W4288445672 hasConcept C535046627 @default.
- W4288445672 hasConcept C542102704 @default.
- W4288445672 hasConcept C558461103 @default.
- W4288445672 hasConcept C71924100 @default.
- W4288445672 hasConceptScore W4288445672C118552586 @default.
- W4288445672 hasConceptScore W4288445672C126322002 @default.
- W4288445672 hasConceptScore W4288445672C142724271 @default.
- W4288445672 hasConceptScore W4288445672C15744967 @default.
- W4288445672 hasConceptScore W4288445672C159110408 @default.
- W4288445672 hasConceptScore W4288445672C16005928 @default.
- W4288445672 hasConceptScore W4288445672C17744445 @default.
- W4288445672 hasConceptScore W4288445672C177713679 @default.
- W4288445672 hasConceptScore W4288445672C189708586 @default.
- W4288445672 hasConceptScore W4288445672C199539241 @default.
- W4288445672 hasConceptScore W4288445672C204787440 @default.
- W4288445672 hasConceptScore W4288445672C2779134260 @default.
- W4288445672 hasConceptScore W4288445672C2779473830 @default.
- W4288445672 hasConceptScore W4288445672C2779951463 @default.
- W4288445672 hasConceptScore W4288445672C2779980618 @default.
- W4288445672 hasConceptScore W4288445672C535046627 @default.
- W4288445672 hasConceptScore W4288445672C542102704 @default.
- W4288445672 hasConceptScore W4288445672C558461103 @default.
- W4288445672 hasConceptScore W4288445672C71924100 @default.
- W4288445672 hasIssue "6" @default.
- W4288445672 hasLocation W42884456721 @default.
- W4288445672 hasOpenAccess W4288445672 @default.
- W4288445672 hasPrimaryLocation W42884456721 @default.
- W4288445672 hasRelatedWork W1989604042 @default.
- W4288445672 hasRelatedWork W2079135330 @default.
- W4288445672 hasRelatedWork W2106215955 @default.
- W4288445672 hasRelatedWork W2108747860 @default.
- W4288445672 hasRelatedWork W2171020547 @default.
- W4288445672 hasRelatedWork W2755835155 @default.
- W4288445672 hasRelatedWork W2799778172 @default.
- W4288445672 hasRelatedWork W4205745512 @default.
- W4288445672 hasRelatedWork W4386686744 @default.
- W4288445672 hasRelatedWork W2114915478 @default.
- W4288445672 hasVolume "24" @default.
- W4288445672 isParatext "false" @default.
- W4288445672 isRetracted "false" @default.
- W4288445672 workType "article" @default.